SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-16
👔
GALECTIN THERAPEUTICS INC
@GALT_InsiderForm 4 Filing: Jamil Khurram Sells $132,684.5 of $GALT
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
GALECTIN THERAPEUTICS INC
Ticker: $GALT
Transaction Value
$132,684.5
Price/Share: $4.08
transaction date
2026-07-14
Shares: 32,500
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Jamil Khurram, holds the title of Chief Medical Officer at GALECTIN THERAPEUTICS INC.
On 2026-07-14, the insider transacted 32,500 shares.The shares were transacted at a weighted average price of $4.08 per share, resulting in a total market-relevant value of $132,684.5.
Executive Summary Summary
Jamil Khurram (Chief Medical Officer) sold $133K of $GALT
Post-Transaction Position: 0 shares
SEC Accession No: 0001133416-26-000063 (CIK: 2032345)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.